Bliss GVS Pharma - Quaterly Results

07 Nov 2022 Evaluate
Net sales declined -20.40%  to  Rs. 1388.49 million from Rs. 1744.28 millions.Profit after tax improved marginally to Rs. 254.47  millions for the quarter ended September 2022 from Rs. 247.27 millions of corresponding previous quarter.Operating Profit saw a handsome growth to 408.67 millions from 387.51 millions in the quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1388.49 1744.28 -20.40 2861.29 3074.58 -6.94 6363.57 4655.13 36.70
Other Income 142.31 59.87 137.70 328.65 138.82 136.75 326.28 176.83 84.52
PBIDT 408.67 387.51 5.46 786.48 725.77 8.36 1418.26 1091.43 29.95
Interest 18.39 5.35 243.74 38.81 18.35 111.50 43.24 41.94 3.10
PBDT 390.28 382.16 2.12 747.67 707.42 5.69 1402.47 1049.49 33.63
Depreciation 37.35 34.46 8.39 74.09 69.27 6.96 138.47 137.62 0.62
PBT 352.93 347.70 1.50 673.58 638.15 5.55 1264.00 911.87 38.62
TAX 98.46 100.43 -1.96 172.67 174.30 -0.94 337.36 236.86 42.43
Deferred Tax 7.55 -8.54 -188.41 -4.70 1.32 -456.06 7.68 11.69 -34.30
PAT 254.47 247.27 2.91 500.91 463.85 7.99 926.64 675.01 37.28
Equity 103.89 103.51 0.37 103.89 103.51 0.37 103.68 103.15 0.51
PBIDTM(%) 29.43 22.22 32.48 27.49 23.61 16.44 22.29 23.45 -4.94

Bliss GVS Pharma Share Price

131.50 2.50 (1.94%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.